Propanc Biopharma Plans to Purchase $100 Million Worth of Ethereum in the Next 12 Months
By: theblockbeats.news|2025/09/02 13:52:27
BlockBeats News, September 2nd, US-listed biopharmaceutical company Propanc Biopharma (PPCB) announced plans to buy $100 million worth of Ethereum in the next 12 months. Propanc Biopharma stated that this move will enhance its overall corporate strategy in various areas such as cryptocurrency investment, drug development, and asset acquisition.
U.S. publicly traded company Empery Digital has announced an additional purchase of 16.51 BTC, increasing its total holdings to 4,081.39 BTC.
Data: Avalon Labs has collected a total of $5.48 million in fees since June.
You may also like
Share
Gainers
Latest Crypto News
07:45
A whale bought 65.65 WBTC the day before liquidation and suffered a loss of $316,000.
07:15
Ripple Labs Granted Expansion of Payment Business Operations in Singapore
06:45
Arthur Hayes: If Tether holds illiquid assets, any mishap could trigger questions about overcollateralization
06:45
The current mainstream CEX and DEX funding rate indicates a weakening bearish market sentiment.
06:15
Lawyer's Interpretation of the "1128" Regulation Policy: Focus on Regulating Activities Using Stablecoins for Illegal Foreign Exchange交
Read more
Community
Customer Support:@weikecs
Business Cooperation:@weikecs
Quant Trading & MM:bd@weex.com
VIP Services:support@weex.com